Serratia infection risk factors

Jump to navigation Jump to search

Serratia infection Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Serratia infection from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Serratia infection risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Serratia infection risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Serratia infection risk factors

CDC on Serratia infection risk factors

Serratia infection risk factors in the news

Blogs on Serratia infection risk factors

Directions to Hospitals Treating Serratia infection

Risk calculators and risk factors for Serratia infection risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Common risk factors for the development of Serratia infection include recent surgery (head, abdominal, ocular, genitourinary, or cardiac valve replacement), recent instrumentation, recent procedures (bronchoscopy, urinary catheterization), mechanical ventilation, recent trauma or burn, blood transfusions, diabetes mellitus, use of contact lenses, and IV drug use.[1][2][3][4][5][6]

Risk Factors

Risk factors for the development of Serratia infection include:[1][2][3][4][5][6]

  • Parenteral feeding
  • Mechanical ventilation
  • Bronchoscopy
  • Head trauma
  • Recent head, abdominal, ocular, or genitourinary surgery
  • Surgical scar
  • Recent burn
  • Recent cellulitis, phlebitis, or other skin infection
  • Cardiac valve replacement
  • Blood transfusions
  • Catheter placement
  • Diabetes mellitus
  • Urinary tract obstruction
  • IV Drug use
  • Use of contact lenses

References

  1. 1.0 1.1 Ostrowsky BE, Whitener C, Bredenberg HK, Carson LA, Holt S, Hutwagner L; et al. (2002). "Serratia marcescens bacteremia traced to an infused narcotic". N Engl J Med. 346 (20): 1529–37. doi:10.1056/NEJMoa012370. PMID 12015392.
  2. 2.0 2.1 Sunenshine RH, Tan ET, Terashita DM, Jensen BJ, Kacica MA, Sickbert-Bennett EE; et al. (2007). "A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy". Clin Infect Dis. 45 (5): 527–33. doi:10.1086/520664. PMID 17682984.
  3. 3.0 3.1 Horcajada JP, Martínez JA, Alcón A, Marco F, De Lazzari E, de Matos A; et al. (2006). "Acquisition of multidrug-resistant Serratia marcescens by critically ill patients who consumed tap water during receipt of oral medication". Infect Control Hosp Epidemiol. 27 (7): 774–7. doi:10.1086/504445. PMID 16807859.
  4. 4.0 4.1 Mills J, Drew D (1976). "Serratia marcescens endocarditis: a regional illness associated with intravenous drug abuse". Ann Intern Med. 84 (1): 29–35. PMID 1106290.
  5. 5.0 5.1 Pinna A, Usai D, Sechi LA, Carta A, Zanetti S (2011). "Detection of virulence factors in Serratia strains isolated from contact lens-associated corneal ulcers". Acta Ophthalmol. 89 (4): 382–7. doi:10.1111/j.1755-3768.2009.01689.x. PMID 19845561.
  6. 6.0 6.1 Friedman ND, Peterson NB, Sumner WT, Alexander BD (2003). "Spontaneous dermal abscesses and ulcers as a result of Serratia marcescens". J Am Acad Dermatol. 49 (2 Suppl Case Reports): S193–4. doi:10.1067/mjd.2003.312. PMID 12894121.